Press release
AI-Based Clinical Trial Solution Providers Market Top Players -Antidote Technologies, Inc. (US), AiCure, LLC (US), Deep 6 AI (US), Deep Lens Inc. (US).
AI-Based Clinical Trial Solution Providers Market
InsightAce Analytic Pvt. Ltd. reveals the release of a market assessment report on the "Global AI-based Clinical Trial Solution Providers Market Trends, Industry Competition Analysis, Revenue and Forecast To 2030."
Get Free Access to Demo Report, Excel Pivot and ToC: www.insightaceanalytic.com/request-sample/1430
According to InsightAce Analytic's most recent research, the global market for AI-based clinical trial solution providers is predicted to grow rapidly over the forecast period. By geography, North America is likely to lead the market.
Clinical trial protocols and research rely heavily on artificial intelligence. AI-powered platforms improve clinical data interpretability and contribute to the resolution of huge and complicated difficulties in clinical research and medical product development. AI platforms enable researchers to examine new compounds and therapeutics in silico.
Advanced digital and medical technologies, rapid innovation of new AI-based platforms/systems, high prevalence of chronic and infectious diseases, increased healthcare expenditure, rising government investments for R&D of clinical trials, increasing use of AI and machine learning techniques, and rising awareness among researchers about AI platforms are expected to boost market growth in the forecast years. Furthermore, biopharmaceutical companies fuel growth in the market for AI-based clinical trial solution providers, since the majority of these organizations choose to speed clinical trials using AI platforms and sophisticated planning and design approaches.
However, rigorous rules governing AI-based clinical trial approvals, as well as a lack of awareness of AI applications or platforms, are projected to limit market growth possibilities over the projection period (2020-2030).
Geographically, North America dominated the AI-based clinical trial solution providers market in 2020 and will continue to do so over the estimated timeframe, followed by Europe, owing to rising human health diseases, rapid adoption of new techniques, and increased clinical R&D funding by the government. The Asia-Pacific region is expected to grow this market in the next years as clinical trials and research investments increase.
Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2024-02
Major market players operating in the AI-based clinical trial solution providers market include Antidote Technologies, Inc. (US), AiCure, LLC (US), Deep 6 AI (US), Deep Lens Inc. (US), Innoplexus (Germany), Intelligencia.ai (US), MEDIAN Technologies (France), Mendel.ai (US), Phesi (US), Saama Technologies (US), Unlearn.AI, Inc. (US), and Trials.ai (US), among others.
A few of the developments in the market are as follows:
• In October 2021, Deep Lens (US) collaborated with Southern Oncology Specialists to use the AI-based solution VIPER for improving clinical trial matching. This partnership brings more precision medicine trials to the practice and broadens the practice's existing research program.
• In September 2021, Deep 6 AI (US), the leader in artificial intelligence (AI)-based clinical trial acceleration software (CTAS), introduced Deep 6 for Life Sciences, a novel suite of AI software solutions for life science sponsors and CROs, built on its industry-leading clinical trial acceleration platform. Deep 6 for Life Sciences brings a new level of data-driven precision and insight to sponsors' interventional and observational studies, saving them months and significantly de-risking their research efforts.
• In March 2020, Innoplexus AG (Germany) opened its proprietary Ontosight® AI search platform freely available to all medical researchers worldwide to help fight the COVID-19 pandemic.
Unlock Your GTM Strategy: www.insightaceanalytic.com/customisation/1430
Market Segments
AI-based Clinical Trial Solution Providers Market, by Target Therapeutic Area, 2020-2030 (Value US$ Mn)
• Cardiovascular Disorders
• CNS Disorders
• Infectious Disorders
• Metabolic Disorders
• Oncological Disorders
• Other Disorders
AI-based Clinical Trial Solution Providers Market, by Trial Phase, 2020-2030 (Value US$ Mn)
• Early Phase 1
• Phase 1
• Phase 2
• Phase 3
• Phase 4
AI-based Clinical Trial Solution Providers Market, by End-Users, 2020-2030 (Value US$ Mn)
• Pharmaceutical Companies
• Academia and Other Users
AI-based Clinical Trial Solution Providers Market, by Region, 2020-2030 (Value US$ Mn)
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa
North America AI-based Clinical Trial Solution Providers Market, by Country, 2020-2030 (Value US$ Mn)
• U.S.
• Canada
Europe AI-based Clinical Trial Solution Providers Market, by Country, 2020-2030 (Value US$ Mn)
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe
Asia Pacific AI-based Clinical Trial Solution Providers Market, by Country, 2020-2030 (Value US$ Mn)
• India
• China
• Japan
• South Korea
• Australia & New Zealand
Latin America AI-based Clinical Trial Solution Providers Market, by Country, 2020-2030 (Value US$ Mn)
• Brazil
• Mexico
• Rest of Latin America
Middle East & Africa AI-based Clinical Trial Solution Providers Market, by Country, 2020-2030 (Value US$ Mn)
• GCC Countries
• South Africa
• Rest of Middle East & Africa
Empower Your Decision-Making with 180 Pages Full Report @ www.insightaceanalytic.com/buy-report/1430
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
info@insightaceanalytic.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release AI-Based Clinical Trial Solution Providers Market Top Players -Antidote Technologies, Inc. (US), AiCure, LLC (US), Deep 6 AI (US), Deep Lens Inc. (US). here
News-ID: 3788443 • Views: …
More Releases from InsightAce Analytic Pvt. Ltd
Sustainable Packaging Market Strategic Industry Overview and Forecast 2026 to 20 …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Sustainable Packaging Market Size, Share & Trends Analysis Report By Material (Paper & Paperboard, Plastic, Metal, Glass), Process (Recycled, Reusable, Degradable), Function (Active, Molded Pulp, Alternate Fiber), Application (Food & Beverage, Healthcare, Others) & Layer (primary, secondary, and tertiary)- Market Outlook And Industry Analysis 2034"
The global Sustainable Packaging Market is estimated to reach over USD…
SCADA Market Insights Highlighting Technological Advancements in Wireless Sensor …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global SCADA Market Size, Share & Trends Analysis Report By Offering (Hardware, Software, Services), Component (Programmable Logic Controller, Remote Terminal Unit, Human-Machine Interface), End User (Process Industries, Discrete Manufacturing, Utilities), Region, Market Outlook And Industry Analysis 2034"
The global SCADA market is estimated to reach over USD 25.0 billion by the year 2034, exhibiting a CAGR of…
Biocomputer Based on Organoids Market Poised for 16.3% CAGR Driven by Brain Orga …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Biocomputer Based on Organoids Market Size, Share & Trends Analysis Report By Organoid Type (Brain Organoids, Other Organoids), Application (Biological Computing, Neuroscience Research, Drug Discovery and Testing, Personalized Medicine, Regenerative Medicine), Technology (Microfluidic Systems Microelectrode Arrays (MEAs), Brain-Machine Interfaces, CRISPR and Gene Editing), End-User (Academic and Research Institutes, Biotechnology and Pharmaceutical Companies, Technology Companies, Contract…
Postbiotic Supplements Market Drivers Include Functional Nutrition and Bioactive …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Postbiotic Supplements Market - (By Type (Bacteria, Yeast), By Form (Soft gels, Capsules/Tablets, Powder/ Granules, Others), By Application (Personal Care and Cosmetics, Food and Beverages, Animal Feed, Pharmaceuticals, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic, the Global Postbiotic Supplements Market is valued at USD 12.8…
More Releases for Trial
Clinical Trial Investigative Site Network Market Clinical Trial Investigative Si …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Clinical Trial Investigative Site Network Market - (By Therapeutic Areas (Oncology, Cardiology, CNS, Pain Management, Endocrine, Others), By Phase (Phase I, Phase II, Phase III, Phase IV), By End-use (Sponsor, CRO)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic, the Global Clinical Trial Investigative Site Network Market…
Transformative Trends Impacting the Electronic Trial Master File (eTMF) Systems …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Electronic Trial Master File (eTMF) Systems Market Size By 2025?
The market size of the electronic trial master file (eTMF) systems has experienced fast growth over recent years. The market is projected to increase from $1.36 billion in 2024 to $1.55 billion in 2025, with…
Transformative Trends Impacting the Electronic Trial Master File (eTMF) Systems …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Electronic Trial Master File (eTMF) Systems Market Size By 2025?
The market size of the electronic trial master file (eTMF) systems has experienced fast growth over recent years. The market is projected to increase from $1.36 billion in 2024 to $1.55 billion in 2025, with…
Clinical Trial Imaging market
The Clinical Trial Imaging market crossed the US$ 1.09 billion mark in 2022 and is expected to hit US$ 1.94 billion by 2030, recording a CAGR of 7.5% during the forecast period.
Rising R&D spending, a rapidly growing pharmaceutical industry, and an increase in the number of contract research organizations are some of the major factors driving the market's growth. There has been an increase in pharmaceutical companies due to the…
Clinical Trial Logistics
Clinical Trial Logistics
16th to 17th May 2011, Marriott Regents Park, London, United Kingdom.
It currently costs just over £500 million ($800 million) to bring a new chemical to market and development timelines continue to fall in the 10-15 year range. A key reason for high R&D costs is due to logistical failures including failure to recruit patients on time. A way to avoid this is to move clinical trials…
Clinical Trial Logistics
Announcing SMi's 5th annual…
Clinical Trial Logistics conference
16th and 17th May 2011, Central London, UK
www.smi-online.co.uk/2011logistics-london6.asp
It currently costs just over £500 million ($800 million) to bring a new chemical to market and development timelines continue to fall in the 10-15 year range. A key reason for high R&D costs is due to logistical failures including failure to recruit patients on time. A way to avoid this is to move clinical…
